McKesson Ventures
  • Portfolio
  • News & Insights
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicators Used for Checkpoint Inhibitor Therapy

by McKesson Ventures | Apr 8, 2024 | Press Releases

On Monday, April 8, 2024, Florida-based biotechnology research company Aster Insights announced that it has partnered with the Food & Drug Administration (FDA) to examine the relationship between the scoring algorithms used in diagnostic testing and key patient...

ORIEN to Present Abstracts at 65th Annual ASH Meeting Utilizing Aster Insights’ Avatar Platform

by McKesson Ventures | Dec 8, 2023 | Press Releases

Aster Insights has announced three upcoming presentations at the 2023 American Society of Hematology (ASH) Annual Meeting, which will be held from December 9-12 in San Diego, CA. Three ORIEN scientists from Moffitt Cancer Center will present key findings on multiple...

Recent Posts

  • Latent Expands AI Platform to Unlock Access to a New Generation of Medicines
  • Komodo Health Wins 2026 Fierce AI Innovation Award for Commercial Strategy & Launch from Fierce Pharma
  • Silver and LYNX Launch Production AI Claims Automation to Help TPAs Modernize Claims Processing
  • HarmonyCares Ranks Among Medicare’s Top ACO REACH Performers for 2024
  • UNC Health Scales Medication Access By Over 45% Without Adding Headcount Using Latent Health’s Pharmacy Intelligence Platform
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings